The results showed that the expression levels of both circCSPP1 and EGR1 were higher in the prostate cancer tissues than in the benign tissues, whereas the expression of miR-520h was lower in prostate cancer tissues than that in benign tissues (Figure 7F). This evidence concerns the gene EGR1 and prostate carcinoma.